297 related articles for article (PubMed ID: 28464368)
1. Leptomeningeal Enhancement at 7T in Multiple Sclerosis: Frequency, Morphology, and Relationship to Cortical Volume.
Harrison DM; Wang KY; Fiol J; Naunton K; Royal W; Hua J; Izbudak I
J Neuroimaging; 2017 Sep; 27(5):461-468. PubMed ID: 28464368
[TBL] [Abstract][Full Text] [Related]
2. No association between cortical lesions and leptomeningeal enhancement on 7-Tesla MRI in multiple sclerosis.
Ighani M; Jonas S; Izbudak I; Choi S; Lema-Dopico A; Hua J; O'Connor EE; Harrison DM
Mult Scler; 2020 Feb; 26(2):165-176. PubMed ID: 31573837
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal Persistence of Meningeal Enhancement on Postcontrast 7T 3D-FLAIR MRI in Multiple Sclerosis.
Jonas SN; Izbudak I; Frazier AA; Harrison DM
AJNR Am J Neuroradiol; 2018 Oct; 39(10):1799-1805. PubMed ID: 30213813
[TBL] [Abstract][Full Text] [Related]
4. Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.
Harrison DM; Allette YM; Zeng Y; Cohen A; Dahal S; Choi S; Zhuo J; Hua J
PLoS One; 2024; 19(5):e0300298. PubMed ID: 38809920
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal Contrast Enhancement Is Related to Focal Cortical Thinning in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional MRI Study.
Bergsland N; Ramasamy D; Tavazzi E; Hojnacki D; Weinstock-Guttman B; Zivadinov R
AJNR Am J Neuroradiol; 2019 Apr; 40(4):620-625. PubMed ID: 30872420
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Leptomeningeal Contrast Enhancement Using Pre-and Postcontrast Subtraction 3D-FLAIR Imaging in Multiple Sclerosis.
Zivadinov R; Ramasamy DP; Hagemeier J; Kolb C; Bergsland N; Schweser F; Dwyer MG; Weinstock-Guttman B; Hojnacki D
AJNR Am J Neuroradiol; 2018 Apr; 39(4):642-647. PubMed ID: 29439125
[TBL] [Abstract][Full Text] [Related]
7. 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions.
Zurawski J; Tauhid S; Chu R; Khalid F; Healy BC; Weiner HL; Bakshi R
Mult Scler; 2020 Feb; 26(2):177-187. PubMed ID: 31714181
[TBL] [Abstract][Full Text] [Related]
8. 7T MPFLAIR versus MP2RAGE for Quantifying Lesion Volume in Multiple Sclerosis.
Spini M; Choi S; Harrison DM
J Neuroimaging; 2020 Jul; 30(4):531-536. PubMed ID: 32569408
[TBL] [Abstract][Full Text] [Related]
9. Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice.
Titelbaum DS; Engisch R; Schwartz ED; Napoli SQ; Sloane JA; Samaan S; Katz JD; Lathi ES
J Neuroimaging; 2020 Nov; 30(6):917-929. PubMed ID: 32830899
[TBL] [Abstract][Full Text] [Related]
10. Leptomeningeal contrast enhancement is associated with progression of cortical atrophy in MS: A retrospective, pilot, observational longitudinal study.
Zivadinov R; Ramasamy DP; Vaneckova M; Gandhi S; Chandra A; Hagemeier J; Bergsland N; Polak P; Benedict RH; Hojnacki D; Weinstock-Guttman B
Mult Scler; 2017 Sep; 23(10):1336-1345. PubMed ID: 27811339
[TBL] [Abstract][Full Text] [Related]
11. Seven-Tesla Magnetization Transfer Imaging to Detect Multiple Sclerosis White Matter Lesions.
Chou IJ; Lim SY; Tanasescu R; Al-Radaideh A; Mougin OE; Tench CR; Whitehouse WP; Gowland PA; Constantinescu CS
J Neuroimaging; 2018 Mar; 28(2):183-190. PubMed ID: 28944575
[TBL] [Abstract][Full Text] [Related]
12. Association of retinal atrophy with cortical lesions and leptomeningeal enhancement in multiple sclerosis on 7T MRI.
Mizell R; Chen H; Lambe J; Saidha S; Harrison DM
Mult Scler; 2022 Mar; 28(3):393-405. PubMed ID: 34125629
[TBL] [Abstract][Full Text] [Related]
13. Highly Sensitive 3-Tesla Real Inversion Recovery MRI Detects Leptomeningeal Contrast Enhancement in Chronic Active Multiple Sclerosis.
Okar SV; Dieckhaus H; Beck ES; Gaitán MI; Norato G; Pham DL; Absinta M; Cortese IC; Fletcher A; Jacobson S; Nair G; Reich DS
Invest Radiol; 2024 Mar; 59(3):243-251. PubMed ID: 37493285
[TBL] [Abstract][Full Text] [Related]
14. Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.
Hildesheim FE; Ramasamy DP; Bergsland N; Jakimovski D; Dwyer MG; Hojnacki D; Lizarraga AA; Kolb C; Eckert S; Weinstock-Guttman B; Zivadinov R
Mult Scler Relat Disord; 2021 Jan; 47():102653. PubMed ID: 33333417
[TBL] [Abstract][Full Text] [Related]
15. A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis.
Dahal S; Allette YM; Naunton K; Harrison DM
Mult Scler Relat Disord; 2024 Jan; 81():105344. PubMed ID: 38035495
[TBL] [Abstract][Full Text] [Related]
16. Investigation of leptomeningeal enhancement in MS: a postcontrast FLAIR MRI study.
Eisele P; Griebe M; Szabo K; Wolf ME; Alonso A; Engelhardt B; Hennerici MG; Gass A
Neurology; 2015 Feb; 84(8):770-5. PubMed ID: 25616480
[TBL] [Abstract][Full Text] [Related]
17. Thalamic lesions in multiple sclerosis by 7T MRI: Clinical implications and relationship to cortical pathology.
Harrison DM; Oh J; Roy S; Wood ET; Whetstone A; Seigo MA; Jones CK; Pham D; van Zijl P; Reich DS; Calabresi PA
Mult Scler; 2015 Aug; 21(9):1139-50. PubMed ID: 25583851
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
Absinta M; Vuolo L; Rao A; Nair G; Sati P; Cortese IC; Ohayon J; Fenton K; Reyes-Mantilla MI; Maric D; Calabresi PA; Butman JA; Pardo CA; Reich DS
Neurology; 2015 Jul; 85(1):18-28. PubMed ID: 25888557
[TBL] [Abstract][Full Text] [Related]
19. Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis.
Jonkman LE; Fleysher L; Steenwijk MD; Koeleman JA; de Snoo TP; Barkhof F; Inglese M; Geurts JJ
Mult Scler; 2016 Sep; 22(10):1306-14. PubMed ID: 26672996
[TBL] [Abstract][Full Text] [Related]
20. Decoding Gray Matter Involvement in Multiple Sclerosis via Imaging.
Zivadinov R; Schweser F; Jakimovski D; Bergsland N; Dwyer MG
Neuroimaging Clin N Am; 2024 Aug; 34(3):453-468. PubMed ID: 38942527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
